Skip to main content
logo
Faeth Therapeutics, Inc. (FTH)
NASDAQ: FTH · Real-Time Price · USD
40.05
+1.05 (2.69%)
At close: Sep 4, 2026, 4:00 PM EDT
40.50
+0.45 (1.12%)
After-hours: Sep 4, 2026, 7:30 PM EDT

Faeth Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1,03513121746177
Market Cap Growth
9352.95%9.18%-28.74%-62.21%-74.21%-
Enterprise Value
849-10-30-48-6222
Last Close Price
40.0510.679.8013.8429.80116.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
5.980.720.320.270.441.21
P/TBV Ratio
5.980.720.320.270.441.21

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.080.100.100.080.02
Net Debt / Equity Ratio
-1.07-1.06-0.98-0.92-0.96-0.99
Net Debt / EBITDA Ratio
5.070.891.241.672.033.95
Net Debt / FCF Ratio
5.490.961.511.852.524.50
Quick Ratio
19.464.987.5911.6511.8230.20
Current Ratio
19.695.067.7011.9211.9830.38
Return on Equity (ROE)
-195.26%-74.01%-58.40%-40.52%-38.88%-45.31%
Return on Assets (ROA)
-20.79%-40.81%-33.05%-24.04%-23.10%-26.83%
Return on Capital Employed (ROCE)
-20.50%-119.50%-79.30%-53.90%-45.90%-25.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-18.89%-156.67%-244.65%-197.14%-106.15%-20.73%
FCF Yield
-3.27%-152.10%-201.32%-186.17%-85.96%-18.19%
Buyback Yield / Dilution
-88.34%-0.40%10.15%8.96%-10.80%-1618.88%
SEC Filings: 10-K · 10-Q